炎症性腸疾患患者のための適切な遠隔医療の調査
Masaro Nagamatsu1, Kayoko Matsushima1, Junya Shiota1
1Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Internal medicine (Tokyo, Japan)
|August 20, 2025
まとめ
遠隔医療は炎症性腸疾患 (IBD) の患者に 症状を悪化させずに使用できます しかし,IBDのケアにおける遠隔医療の最適化には,患者の好みや特定のニーズを理解することが不可欠です.
科学分野:
- 胃腸内科
- デジタル・ヘルス
- 医療サービス研究
背景:
- 炎症性腸疾患 (IBD) の管理には,患者の継続的なモニタリングが必要です.
- 遠隔医療はIBDの治療へのアクセスと便利さを改善する 解決策となる可能性があります
- IBDにおける遠隔医療の実現可能性と患者の受容性を理解することは不可欠です.
研究 の 目的:
- IBD患者に遠隔医療を適用する条件を探求する.
- 遠隔医療がIBD患者の状態に悪影響を及ぼさないことを示すために
- IBD患者のニーズを満たす遠隔医療の形式を明確にする.
主な方法:
- IBD患者267人の医療記録を遡及分析した (研究1).
- 遠隔医療の認識に関するIBD患者113人のアンケート調査 (研究2)
- 遠隔医療がIBDの治療と患者のアウトカムに与える影響を調査する.
主要な成果:
- IBDの治療における遠隔医療の実施は,患者の状態に重大な悪影響を及ぼさなかった.
- 病気の持続時間,以前の再発,およびHbレベルは,遠隔医療の使用ではなく,再発に関連していました.
- IBD患者の多くは 直接の診察を好むが 時間が限られている人は 遠隔医療を好む.
結論:
- 遠隔医療はIBD患者の健康に悪影響を及ぼすことなく 実行可能な選択肢です
- IBDにおける遠隔医療のための最適な条件を定義するには,さらなる研究が必要です.
- 遠隔医療を組み込んだ患者中心のIBD治療システムの開発が必要である.
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
01:29Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
267
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
267
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231
01:30Inflammatory Bowel Disease II: Crohn's Disease
382
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
382
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
202
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
202